Start here
This is a free, public reference for tech transfer, process validation, drug product, CDMO governance, and regulatory CMC in cell, gene, and RNA medicines. Written for everyone, from people new to the field through senior program leaders.
What I get from this: nothing, except knowing it helped someone avoid learning things the hard way. That's genuinely enough. If it's not useful to you, the tab close button is right there. And if something is wrong, outdated, or missing, I actually want to know.
This site provides public educational information based on publicly available regulatory guidance, laws, and standards. It is not regulatory advice, legal advice, or inspection strategy. Nothing here replaces the need to read primary sources, apply professional judgment, and consult qualified experts for your specific situation.
Where are you right now?
Three entry levels, by depth. Pick the one that matches today, not the one you aspire to.
- 01Browse Beginner articles →Beginner
New to advanced therapy CMC
You've heard terms like tech transfer, PPQ, CDMO, or CMC and want to understand what they mean and why they matter.
- 02Browse Intermediate articles →Intermediate
Practitioner running a transfer or a campaign
You're moving a process, writing a protocol, running a PPQ campaign, or overseeing a CDMO and need operational depth.
- 03Browse Advanced articles →Advanced
Senior practitioner or program lead
You're designing a tech transfer program, preparing for a PAI, authoring a BLA CMC section, or building CDMO governance from scratch.
What's your job?
The same regulation looks different depending on what you do every day.
Tech Transfer & NPI
- Person-in-Plant Oversight: What a PIP Is Actually For
- Technology Transfer for Advanced Therapies: How a Transfer Actually Gets Done
Process Validation, PPQ & CPV
- Continued Process Verification: Building a Stage 3 Program That Actually Monitors
- One Validation Mindset, Six Modalities
- PPQ Readiness: The Prerequisites That Decide Success Before Batch One
- Validation Master Planning for a Clinical-Stage Biotech: Getting Started the Right Way
Drug Product & Fill-Finish
- Building a Container Closure Integrity Program Under USP <1207>
- Cold Chain for Advanced Therapies: Qualifying Cryoshippers and Dry-Vapor Shippers
- Filter Validation for Biologics and Oligonucleotides
- Formulation Development Patterns Across Advanced Therapies
What this site is, and is not
- Free, public educational content on advanced therapy CMC: tech transfer, process validation, drug product, CDMO governance, and regulatory CMC
- Based on publicly available regulatory guidance, laws, and standards
- Written at three levels: beginner, intermediate, and advanced
- Two guided learning paths with a specific recommended reading sequence
- Practical framing: what to do, why, what can go wrong, what a reviewer or inspector actually looks for
- Content distinguishes between legal requirements, regulatory expectations, and practitioner judgment calls
- Not regulatory or legal advice, do not rely on it as a substitute for qualified consultation
- Not a guarantee that following any content will satisfy regulatory requirements
- Not company-specific, all content uses generic, public examples with no employer information
- Not always current, regulatory guidance evolves; always verify against primary sources
- Not a template repository alone, content here requires adaptation to your context
- Not affiliated with any regulatory agency, employer, CDMO, or trade association
Most useful pages
- →Topic Areas
Five topic areas covering tech transfer, validation, drug product, CDMO governance, and regulatory CMC
- →Guided Learning Paths
Two sequenced paths: own your first tech transfer, and PPQ from zero
- →Templates & Protocols
Ready-to-use SOPs, protocols, checklists, and forms, each with a worked filled example
- →Glossary
Plain-language definitions for 30+ tech transfer, validation, drug product, and regulatory CMC terms
- →Full Article Index
Every article, sorted newest first
- →Search
Search across titles, summaries, tags, and section headings